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Abstract
Background: As shown previously, the submandibular (SM) lymph node (LN) is required for
priming the immune response during corneal graft rejection. In this study, we wished to determine
whether corneal grafts at "high-risk" of rejection were also protected after selective SM LN
removal and if so to investigate whether this improved corneal graft survival was due to induction
of specific regulatory/suppressor cells or was due to immunological "ignorance".
Methods: Two sets of experiments were performed. (1) Adoptive transfer of possible regulatory
splenocytes from mice with long-term accepted corneal graft after SM LN removal. (2) SM LN
removal and corneal grafts in "high-risk" hosts, which had been (A) subjected to corneal trauma
with vascularization or (B) allosensitized by previous corneal graft or (C) allosensitized by previous
skin graft.
Results: Adoptive transfer of splenocytes from tolerant mice after SM LN removal did not
enhance corneal graft survival in naive recipients (p > 0.05).
SM LN removal in mice with corneal vascularization enhanced corneal allograft survival compared
to grafted controls with/without vascularization (p < 0.0001). The removal of the SM LN in mice,
who had already been allosensitized by a previous corneal graft, did not statistically prolong corneal
graft survival (p > 0.05). SM LN removal procedure did not delay rejection of corneal grafts in mice
allosensitized by a previous skin transplant with the same strain combination (p > 0.05).
Conclusion: The results suggest that removal of the SM LN in "high-risk" mice prevents rejection
by mechanisms involving immune "ignorance", since prior allosensitization prevents graft
acceptance after LN removal. In allosensitized recipients the stronger the allosensitization (skin- vs.
corneal graft-presensitization) the greater the possibility of priming for rejection at alternative
draining LN sites.
Background
Draining cervical lymph nodes (LN) play a critical and
necessary role in allosensitization and corneal graft rejec-
tion and their complete removal results in enhanced or
even indefinite graft survival in "low-risk" [1,2] and
prevascularized corneal grafts recipients [3]. We have pre-
viously shown that the submandibular (SM) LN is selec-
tively involved in priming of the alloimmune response
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a second corneal graft [2], while the spleen [1,2] and to a
lesser extent the superficial cervical LN [2] appear to play
a protective role in corneal graft rejection. The mechanism
underlying prolonged graft survival after removal of the
SM LN is not fully understood. One possibility is that the
absence of the LN removes the lymphatic "priming" role
of the draining LN while enhancing the protective role of
the spleen via induction of regulatory T cells [4]. The tol-
erizing T cells from the spleen thus might predominate
after corneal grafting and shift it to the tolerance mode.
The second possibility is that LN removal simply prevents
the priming of the immune response and therefore the
organism is in a state of "alloantigen-ignorance". In order
to determine whether prolonged corneal survival of allo-
grafts after LN removal was due to "ignorance" of priming
via draining LN cells or suppression by spleen derived T
regulatory cells, we have adoptively transferred spleno-
cytes from post-LN removal tolerant mice with clear grafts
to naive mice prior to corneal grafting. To further investi-
gate these two possible mechanisms, the effect of SM LN
removal in three types of "high-risk" recipients was
compared.
Methods
Mice
Inbred female and male mice of the BALB/c (H2d) and
C57BL/10 (H2b) strains 6 to 8 weeks old were obtained
from the animal facility at The Institute of Molecular
Genetics, Academy of Sciences, Prague. The procedures
adopted conformed to the regulations of the Animal
License Act (UK) and to the ARVO Statement for the use
of Animals in Ophthalmic and Vision Research.
Corneal grafting procedure
The procedure was adapted from the technique described
previously by She et al. [5]. Donor corneas (C57BL/10
mice, H-2b) 2 mm in diameter were removed and placed
in balanced salt solution. The recipient mice (BALB/c, H-
2d) were anesthetized by intramuscular injection of a mix-
ture of ketamine and xylazine diluted in saline. To dilate
the pupil a combination of tropicamide 1% and phenyle-
phrine 2.5% drops was used. The recipient right cornea
was marked with a 1.5 mm trephine and excised using
Vannas scissors after penetrating the anterior chamber
with a sharp needle. Provisc® was used to maintain the
anterior chamber throughout the procedure. The donor
graft was sutured into the recipient bed using a running
suture (11-0 Ethilon, Ethicon, UK). After grafting, antibi-
otic ointment (neomycin with bacitracin) was applied to
the eye. The suture was not removed.
Clinical evaluation of rejection
The mice were examined every 2 to 4 days using the oper-
ating microscope. The opacity grade of the grafted cornea
was used as the indicator of graft rejection [6]. The scale of
opacity was zero to four, where grade 2 (vessels of the iris
still distinguishable through a hazy cornea) or more was
considered as graft rejection.
Technique of lymph node removal
A modified technique after Wolvers et al. [7] was used. In
brief, mice were anesthetized by intramuscular injection
of a mixture of ketamine and xylazine diluted in saline.
The right eye was protected from drying by suturing the
eyelids (the suture was removed after recovery). The skin
of the neck was moisturized with chlorhexidine and
shaved with a sharp razor blade. A small incision in the
middle of the head-neck region was made, and with the
aid of an operating microscope, the SM LN was removed
bilaterally. The wound was closed with three interrupted
mattress' sutures (5/0 Ethilon, Ethicon, UK) and cleaned
with chlorhexidine. Seven days after LN removal corneal
grafting was performed.
Adoptive transfer of splenocytes
The procedure described previously by Holan et al. [8]
was used. The spleens of mice, in which the corneal graft
remained clear over the period of 40 days after grafting,
were removed and the splenocytes isolated and injected
(50 × 106 in 0.5 ml of PBS) i.v. into the tail vein of the
BALB/c mice. One day later, corneal grafting in these
recipient mice was performed (15 mice).
Preparation of "high-risk" mice
"High-risk" recipients are mice in which graft rejection is
accelerated. In our experiment, three types of "high-risk"
mice were used:
Group A
Grafts in vascularized corneas. Corneal vascularization
was induced in 17 mice by four interrupted stitches placed
in the four quadrants of the cornea three weeks prior to
corneal allografting. SM LN removal was performed in 8
of these mice 7 days prior to corneal grafting (Figure 1).
Group B
Presensitization by prior corneal grafting. A presensitizing
corneal graft was performed in 11 mice and retained for a
period of 3 weeks. The graft was then replaced by a second
"test" corneal graft, irrespective of the rejection status of
the first graft. SM LN removal was performed in 6 of these
mice 7 days prior to the test graft (Figure 1).
Group C
Presensitization by prior skin grafting. A presensitizing
skin graft was performed in 8 mice and retained for a
period of 3 weeks. A corneal graft with the same strain
combination was then performed. SM LN removal wasPage 2 of 7
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ing (Figure 1).
Skin grafting procedure
The technique of skin grafting was reported previously [9].
In brief: the tail skin of C57BL/10 mice was removed and
placed onto the back of anesthetized (mixture of keta-
mine and xylazine) BALB/c recipients and fixed by a splint
around the thorax. The splint was removed 5 days later
and skin rejection assessed by integrity of the donor graft.
Statistical analysis
To compare survival of corneal grafts between experimen-
tal groups, Mann Whitney U test (GraphPad InStat soft-
ware) by comparing the days of onset of rejection, was
used.
Results
Role of spleen-derived regulatory T cells after SM LN 
removal
Syngeneic splenocytes from mice, which retained fully
accepted clear corneal allografts after SM LN removal [2],
were isolated and adoptively transferred to naive mice. 24
hours later the recipient mice underwent corneal allograft-
ing. No difference in rejection rate was observed between
mice, which had received the splenocytes compared to
untreated control mice. Fourteen of 15 (93%) mice after
adoptive transfer rejected their corneal grafts within the
60 days observation period (Figure 2, p > 0.05 compared
to controls).
Role of immunological "ignorance" versus active 
immunosuppression in corneal graft survival after SM LN 
removal
Mice with prevascularized corneas
In this group (Group A, see Methods), the animals were
examined for up to 60 days post corneal grafting. Within
this period, 100% of prevascularized "high-risk" recipi-
ents (9 mice) rejected their allografts in a "high-risk" man-
ner (i.e. at an accelerated tempo of rejection) compared to
the untreated grafted controls (Figure 3, Table 1). Despite
the "high-risk" status of the graft, removal of SM LN
delayed the rejection onset in all prevascularized recipi-
ents and even prevented rejection in 50% (4 of 8 mice) of
them (Figure 3, p < 0.0001 compared to prevascularized
controls, Table 1).
Mice presensitized by a corneal grafting
This group of animals (Group B, see Methods) was exam-
ined for 60 days after the second corneal graft procedure.
80% (four of five) of the "high-risk" recipients rejected the
allografts within this period. SM LN removal protected
33% (two of six) of the second-graft-recipients from graft
rejection (Figure 4). At day 15 after transplantation, 3 of 5
"high-risk" control mice had rejected while only 1 of 6
"high-risk" mice, who had SM LN removal, had rejected.
This difference was not statistically significant when
median grades were evaluated by day 60 (p > 0.05, Table
1).
Mice presensitized by a skin graft
SM LN removal did not influence the outcome of corneal
grafting in this group (Group C, see Methods) of mice and
both the "high-risk"-LN removal-group and "high-risk"
controls rejected within 12 days from corneal grafting
(Figure 4, p > 0.05, Table 1).
Discussion
The experiments described here were designed to deter-
mine, which of two possibilities was the more probable
explanation for prolonged corneal allograft survival after
removal of the draining LN: a) protection via predomi-
nance of spleen-derived T regulatory cells, or b) protection
via "ignorance" of draining LN T inducer priming cells. In
testing the first hypothesis, we asked whether tolerance,
once established, was transferable by putative regulatory T
cells to a naive recipient. Infectious tolerance as a phe-
nomenon has been described repeatedly in other models
[8,10-12], in which adoptive transfer of whole spleno-
cytes i.v. in a range 50 to 100 × 106, the same numbers as
Procedures performed to create a "high-risk" corneal graft recipientFigure 1
Procedures performed to create a "high-risk" corneal graft recipient. Abbreviations: w – weeks, SM LNR – sub-
mandibular lymph node removal.
Group A: prevascularization
Group B: corneal allografting
Group C: skin allografting +/- SM LNR
Corneal allografting
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We have therefore performed adoptive transfer of 50 × 106
splenocytes from mice with long-term accepted allografts
after removal of the draining LN, to naive animals prior to
corneal grafting, in order to follow previous established
protocols. However, there was no significant difference in
terms of graft acceptance between this group of animals
and normal allografted controls; therefore, prolongation
of corneal graft survival did not seem to be due to the
induction of T regulatory cells. In our experiments, the
spleens were removed from mice 40 days after corneal
graft and the grafts were crystal clear at that time. A period
of 40 days is considered long-term graft survival in mice.
However, it is possible that in a very small proportion of
mice rejection can start even after this period. If spleens
from such mice, in which the corneal graft is clear but high
levels of primed T cells had been induced in the spleen or
other secondary lymphoid organs, such splenocytes
would not transfer tolerance but rather sensitization.
In addressing the second possibility i.e. that loss of prim-
ing of allogeneic T cells is caused by immunological
"ignorance" we hypothesized that we should be able to
prevent rejection in recipient mice, who were at high risk
of rejection without prior exposure to the antigen. In con-
trast, in mice previously sensitized to the antigen i.e., who
were no longer naive, removal of the draining LN should
make no difference to the rate of graft rejection.
Accordingly, we set up three groups of "high-risk" corneal
graft recipients. An experimental model of "high-risk" cor-
neal grafting has been reported frequently [3,13-15] and
Adoptive transfer of splenocytesFigure 2
Adoptive transfer of splenocytes. Percentage of the grafts staying clear during the 60-day period in mice after adoptive 
transfer of splenocytes from mice with clear corneas after submandibular lymph node removal. Compared to controls with 
corneal grafting alone.
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Corneal graft survival in prevascularized recipients. Percentage of the grafts staying clear during the 60-day period in 
"high-risk" mice with prevascularized corneas (Group A) with or without SM LN removal compared to controls with corneal 
grafting alone. *** - p < 0.001 compared to "high-risk" controls. Abbreviations: LN – lymph node, SM – submandibular.
Table 1: Median survival time in all experimental groups of mice
Groups of mice n Median survival time (days)
Naive mice + corneal graft 8, 9 31.0, 28.0
Adoptive transfer of splenocytes + corneal graft 15 25.5
Prevascularized corneas + corneal graft 9 19.0
Prevascularized corneas + LNR + corneal graft 8 56.0
Presensitized by a corneal graft + corneal graft 5 14.0
Presensitized by a corneal graft + LNR + corneal graft 6 21.0
Presensitized by a skin graft + corneal graft 4 10.0
Presensitized by a skin graft + LNR + corneal graft 5 8.0
Abbreviations: LNR – lymph node removal, n – number of mice.
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expressed either as the higher percentage of rejected grafts
or a faster onset of the rejection process. In these models,
however, there may be several reasons for the "high-risk"
status. The method most commonly used in the mouse
model is induced prevascularization of the recipient
cornea [13-15]. This model is equivalent to human recip-
ients with scarred, vascularized corneas for example after
ocular trauma. In corneal grafting, however, several other
factors increase the risk of graft rejection, such as retrans-
plantation in a recipient with previously failed graft, ocu-
lar surface disease, infection of the eye causing scarring
and vascularization, size of the graft, and others. It is
believed that the key factor in regraft models is allosensi-
tization of the recipient, which is achieved in an animal
model by either previous skin [9] or corneal graft [2]. We
have in our study compared the role of SM LN removal in
three types of "high-risk" corneal grafts: prevascularized
non-allosensitized recipients and allosensitized recipients
via prior corneal or skin graft from the same mouse strain.
In animals that were prevascularized but not allosensi-
tized, LN removal resulted in a significant increase in graft
survival, 0 to 50% during the 60-day observation period.
In animals with previous corneal graft, LN removal had a
minor but not statistically significant effect. Corneal grafts
in mice after skin grafting with or without SM LN removal
resulted invariably in 100% rejection by 12 days post cor-
neal grafting. Therefore, priming of the immune system
via separate regional lymphatic system, such as the skin, is
not affected by the SM LN removal and sensitization to
alloantigen is still possible.
Corneal graft survival in allosensitized recipientsFigure 4
Corneal graft survival in allosensitized recipients. Percentage of the grafts staying clear during the 60-day period in 
"high-risk" mice with corneal (Group B) or skin (Group C) graft-allosensitization with of without SM LN removal compared to 
controls with corneal grafting alone. Abbreviations: LN – lymph node, SM – submandibular.
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In our previous studies [2], we have shown that "sham
operation", in which the skin incision without LN
removal is performed, leads to the same level of corneal
graft survival as in the naive untreated control group of
mice. These experiments were therefore not repeated.
At present in clinical corneal graft practice, attention is
paid mostly to aspects such as HLA matching and the use
of immunosuppressants, which are quite broad spectrum
and have significant side effects. The results of these exper-
iments confirming the role of the draining LN in priming
corneal graft rejection suggest that a more targeted or
regional approach to immunosuppresion may be
possible.
Conclusions
The high rate of long-term corneal graft acceptance after
draining LN removal is most likely due to prevention of
priming the immune system to alloantigen. In both "low-
risk" and "high-risk" corneal graft-recipients this effect is
confirmed, but only if the "high-risk" status of the recipi-
ent does not involve allosensitization. However, if the
recipient has already been primed by previous corneal or
skin graft, the protective effect of LN removal is lost, espe-
cially with "strong" alloinducers such as skin grafting.
Thus the stronger the presensitization of the recipient
(skin versus corneal graft), the lesser effect of the LN
removal on the final outcome of corneal grafting.
Abbreviations
LN – lymph node, LNR – lymph node removal, SM –
submandibular.
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